Progestational agents and blood coagulation. V. Changes induced by sequential oral contraceptive therapy.
D001772:Blood Cell Count; D001777:Blood Coagulation / Q000187:drug effects*; D001780:Blood Coagulation Tests; D001789:Blood Group Antigens; D001792:Blood Platelets / Q000187:drug effects; D003276:Contraceptives, Oral / Q000494:pharmacology*; D004338:Drug Combinations; D004997:Ethinyl Estradiol / Q000494:pharmacology; D005164:Factor IX / Q000032:analysis; D005165:Factor V / Q000032:analysis; D005167:Factor VII / Q000032:analysis; D005169:Factor VIII / Q000032:analysis; D005170:Factor X / Q000032:analysis; D005260:Female; D005341:Fibrinolysin / Q000037:antagonists & inhibitors; D006801:Humans; D009640:Norethindrone / Q000494:pharmacology; D010958:Plasminogen / Q000032:analysis; D011247:Pregnancy; D011516:Prothrombin / Q000032:analysis; D011517:Prothrombin Time; D012907:Smoking; D013916:Thrombelastography
D001789:Blood Group Antigens; D003276:Contraceptives, Oral; D004338:Drug Combinations; D004997:Ethinyl Estradiol; D005165:Factor V; D005167:Factor VII; D011516:Prothrombin; D005169:Factor VIII; D005164:Factor IX; D005170:Factor X; D010958:Plasminogen; D005341:Fibrinolysin; D009640:Norethindrone